Market Overview

Mid-Day Market Update: Crude Oil Up 2.8%; Bristol-Myers Squibb Shares Slide After Opdivo Decision

Related BMY
The Week Ahead In Biotech: ASCO Presentations In The Spotlight
Benzinga's Top Upgrades, Downgrades For May 21, 2018
'Safer' Dividend Healthcare Top WallStar Gainers Are Gilead, Sanofi, Amerisource, Anthem, And Johnson, Per Broker May Targets (Seeking Alpha)
Related SGYP
Benzinga's Daily Biotech Pulse: FDA Panel Nod For Akcea, Synergy's Revenue Miss, FDA Warns E-Liquid Makers Again
Benzinga's Daily Biotech Pulse: ARMO Skyrockets On Eli Lilly Deal, Akcea Meets FDA Panel, vTv Alzheimer's Trial Results
Synergy Pharmaceuticals Sees Exodus In Institutional Ownership As Management Ignores Dilution Fears (Seeking Alpha)

Midway through trading Friday, the Dow traded up 0.44 percent to 19,818.98 while the NASDAQ climbed 0.33 percent to 5,558.31. The S&P also rose, gaining 0.40 percent to 2,272.77.

Leading and Lagging Sectors

Non-cyclical consumer goods & services shares gained around 1.02 percent in trading on Friday.

In trading on Friday, healthcare shares slipped by 0.03 percent. Meanwhile, top losers in the sector included Bristol-Myers Squibb Co (NYSE: BMY), down 10 percent, and Synergy Pharmaceuticals Inc (NASDAQ: SGYP), down 9 percent.

Top Headline

General Electric Company (NYSE: GE) reported in-line earnings for its latest quarter, but sales missed expectations.

General Electric posted adjusted Q4 earnings of $0.46 per share on revenue of $33.1 billion. Analysts projected earnings of $0.46 per share on revenue of $33.6 billion.

Equities Trading UP

Interpace Diagnostics Group Inc (NASDAQ: IDXG) shares shot up 27 percent to $5.84 after the company reported a new partnership with Best Med Opinion Ltd of Tel Aviv, Israel.

Shares of Skyworks Solutions Inc (NASDAQ: SWKS) got a boost, shooting up 12 percent to $87.99 after the company reported upbeat results for its first quarter and issued a strong outlook for the second quarter. The company also announced a $500 million buyback plan.

Rightside Group Ltd (NASDAQ: NAME) shares were also up, gaining 14 percent to $9.26. Tucows announced plans to acquire eNom from Rightside for $83.5 million.

Equities Trading DOWN

Pluristem Therapeutics Inc. (NASDAQ: PSTI) shares dropped 23 percent to $1.08. Pluristem disclosed that it has increased its bought deal offering to $15 million of stock and warrants.

Shares of Affimed NV (NASDAQ: AFMD) were down around 21 percent to $1.70. Affimed priced its public offering of 10,000,000 of its common shares at $1.80 per common share.

Bristol-Myers Squibb Co (NYSE: BMY) was down, falling around 9 percent to $50.41 after the company reported that it will not be pursuing accelerated regulatory approval for its lung cancer drug Opvido/Yervoy.


In commodity news, oil traded up 2.80 percent to $53.58 while gold traded up 0.12 percent to $1,203.00.

Silver traded up 0.40 percent Friday to $17.07, while copper rose 0.73 percent to $2.63.


European shares were mostly higher today. The eurozone’s STOXX 600 slipped 0.06 percent, the Spanish Ibex Index rose 0.14 percent, while Italy’s FTSE MIB Index climbed 0.14 percent. Meanwhile the German DAX gained 0.17 percent, and the French CAC 40 rose 0.24 percent while U.K. shares fell 0.06 percent.


The Baker Hughes North American rig count report for the latest week is schedule for release at 1:00 p.m. ET.

San Francisco Federal Reserve Bank President John C. Williams will speak in San Francisco, Calif. at 1:00 p.m. ET.

Posted-In: Earnings News Eurozone Commodities M&A Global Intraday Update Markets


Related Articles (BMY + AFMD)

View Comments and Join the Discussion!